4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.46
+0.01 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
9.42
-0.04 (-0.42%)
After-hours: Apr 28, 2026, 4:10 PM EDT
4D Molecular Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 483 | 429 | 257 | 866 | 719 | 705 | |
| Market Cap Growth | 302.71% | 66.42% | -70.27% | 20.40% | 2.03% | -35.79% | |
| Enterprise Value | -10 | 79 | -268 | 562 | 497 | 478 | |
| Last Close Price | 9.45 | 7.50 | 5.57 | 20.26 | 22.21 | 21.94 | |
| PS Ratio | 5.67 | 5.03 | 6959.14 | 41.80 | 229.93 | 39.09 | |
| PB Ratio | 1.08 | 0.85 | 0.50 | 2.81 | 3.11 | 2.21 | |
| P/TBV Ratio | 0.96 | 0.85 | 0.50 | 2.81 | 3.11 | 2.21 | |
| EV/Sales Ratio | - | 0.92 | - | 27.10 | 158.89 | 26.50 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.05 | 0.05 | 0.07 | 0.05 | |
| Net Debt / Equity Ratio | -0.97 | -0.97 | -0.94 | -0.92 | -0.87 | -0.94 | |
| Net Debt / EBITDA Ratio | 3.25 | 3.25 | 2.63 | 2.62 | 1.88 | 4.28 | |
| Net Debt / FCF Ratio | 4.49 | 4.49 | 3.48 | 3.62 | 2.06 | 3.82 | |
| Asset Turnover | 0.15 | 0.15 | 0 | 0.07 | 0.01 | 0.06 | |
| Quick Ratio | 9.15 | 9.15 | 14.58 | 15.21 | 13.58 | 15.21 | |
| Current Ratio | 9.39 | 9.39 | 14.92 | 15.65 | 14.02 | 15.69 | |
| Return on Equity (ROE) | -27.57% | -27.57% | -39.31% | -37.41% | -39.06% | -24.79% | |
| Return on Assets (ROA) | -17.34% | -17.34% | -26.08% | -23.45% | -22.35% | -13.89% | |
| Return on Capital Employed (ROCE) | -29.90% | -29.90% | -35.40% | -35.20% | -44.70% | -21.20% | |
| Earnings Yield | -29.01% | -32.70% | -62.48% | -11.64% | -14.94% | -10.11% | |
| FCF Yield | -22.70% | -25.58% | -53.74% | -9.07% | -13.65% | -11.10% | |
| Buyback Yield / Dilution | -7.39% | -7.39% | -37.86% | -20.95% | -16.66% | -331.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.